Drug Trial Radar · NCT05536414
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
337
Actual
Start
Sep 12, 2022
Primary completion
May 16, 2025
Study completion May 16, 2025
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Sep 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-arm trial to assess the efficacy, safety, and tolerability of centanafadine once-daily (QD) extended-release (XR) capsules for the treatment of adult subjects diagnosed with Major Depressive Disorder (MDD). The trial will evaluate the efficacy and safety of centanafadine QD XR capsules as monotherapy or as adjunct to the selective serotonin reuptake inhibitor (SSRI), escitalopram.
Conditions
- Major Depressive Disorder
Interventions
CentanafadineDrug
capsule
EscitalopramDrug
capsule
PlaceboDrug
capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to Week 6 in Montgomery-Asberg Depression Rating Scale (MADRS) Total score.Time frame: Baseline, Week 6
Locations
62 sites in 1 country. Site status is shown where the registry gives one.
Yuma CNS Research
Yuma, Arizona
SanRo Clinical Research Group LLC
Bryant, Arkansas
Behavioral Research Specialists-California-Irvine
Glendale, California
Sunwise Clinical Research, LLC - Lafayette - IVY - PPDS
Lafayette, California
OM Research LLC - Lancaster - ClinEdge - PPDS
Lancaster, California
Synergy Research Centers - SRC - ERG - PPDS
Lemon Grove, California
ATP Clinical Research
Orange, California
NRC Research Institute - Orange - PPDS
Orange, California
Prospective Research Innovations
Rancho Cucamonga, California
Anderson Clinical Research - ClinEdge - PPDS
Redlands, California
Lumos Clinical Research
San Jose, California
Syrentis Clinical Research
Santa Ana, California
Schuster Medical Research Institute
Sherman Oaks, California
Viking Clinical Research Ltd
Temecula, California
CNS Clinical Research Group
Coral Springs, Florida
Gulfcoast Clinical Research Center
Fort Myers, Florida
Clinical Neuroscience Solutions Inc
Jacksonville, Florida
South Florida Research Phase I - IV
Miami Springs, Florida
Behavioral Clinical Research, Inc
North Miami, Florida
Clinical Neuroscience Solutions Inc
Orlando, Florida
University of South Florida
Tampa, Florida
Atlanta Center for Medical Research - CenExel ACMR - PPDS
Atlanta, Georgia
iResearch Atlanta - CenExel - PPDS
Decatur, Georgia
Psych Atlanta
Marietta, Georgia
Accelerated Clinical Trials,LLC
Peachtree Corners, Georgia
Northwest Clinical Trials
Boise, Idaho
Flourish Research - Andersonville - PPDS
Chicago, Illinois
Revive Research Institute
Elgin, Illinois
American Medical Research Inc
Oak Brook, Illinois
Louisiana Clinical Research, LLC
Shreveport, Louisiana
MTP Psychiatry, LLC
Baltimore, Maryland
Precise Research Centers - ClinEdge - PPDS
Flowood, Mississippi
Psychiatric Care and Research Center
O'Fallon, Missouri
Bio Behavioral Health
Toms River, New Jersey
Integrative Clinical Trials - Hunt - PPDS
Brooklyn, New York
SPRI Clinical Trials, LLC - ERG - PPDS
Brooklyn, New York
Fieve Clinical Research
New York, New York
Manhattan Behavioral Medicine
New York, New York
Finger Lakes Clinical Research
Rochester, New York
Richmond Behavioral Associates
Staten Island, New York
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.